市場調査レポート

商品コード

1798029

卵子凍結と胚バンク市場の2032年までの予測：サービスタイプ別、保存方法別、年齢層別、技術別、用途別、エンドユーザー別、地域別の世界分析

Egg Freezing and Embryo Banking Market Forecasts to 2032 - Global Analysis By Service Type, Preservation Method, Age Group, Technology, Application, End User and By Geography

出版日: 2025年08月07日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,150 620,300円

レポートPDFを1名様のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回のみ可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (2-5 User License)

USD 5,250 784,717円

レポートPDFを同一事業所（所在地）内の5名までご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回まで可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF & Excel (Site License)

USD 6,350 949,134円

レポートPDFおよびExcelを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は5回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Global Site License)

USD 7,500 1,121,025円

レポートPDFおよびExcelを企業内すべての方に使用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は10回まで可能です。印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=149.47円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Stratistics MRCによると、世界の卵子凍結と胚バンク市場は2025年に53億7,000万米ドルを占め、2032年には117億米ドルに達すると予測され、予測期間中のCAGRは11.8％です。

女性の成熟卵子は、卵子凍結（卵子凍結保存とも呼ばれる）と呼ばれる不妊治療保存法で、後に妊娠する可能性を高めるために取り出され、凍結され、保存されます。細胞の完全性を保つために、卵巣刺激、卵子の摘出、ガラス化による急速凍結が行われます。通常、体外受精（IVF）を通じて、ラボ環境で卵子と精子を受精させることによって作成された胚を作成、凍結、保存するプロセスは、胚バンクとして知られています。これらの技術は、人々やカップルに生殖の柔軟性を与え、加齢や医療的治療の前に生殖能力を維持するのに役立ち、医療的、社会的、または私的な理由で利用されています。

欧州のヒト生殖発生学会によると、世界中で年間300万回以上のARTが行われています。したがって、ARTの採用が拡大するにつれ、短期間の不足に対するニーズも高まっています。

高まる不妊への懸念と医療的理由

ストレス、家族計画の遅れ、ライフスタイルの変化などにより不妊率が上昇した結果、妊孕性温存サービスの必要性が高まっています。加齢による生殖能力の低下を防ぐために、卵子凍結を選択する人も多いです。生殖能力に影響を及ぼす可能性のある治療を受ける前に、がん、子宮内膜症、遺伝病などの医療的問題を抱えている患者も、卵子や胚を保存することが勧められています。生殖技術の進歩は、これらの手術へのアクセスや有効性を向上させています。これらの要素が組み合わさることで、市場の拡大と普及のペースが大きく加速されます。

高額な費用と手頃な価格の問題

手術には高額な治療費、薬代、保管料がかかります。多くの個人、特に低・中所得地域では、こうしたサービスを受ける余裕がないです。保険適用が限られているため、経済的負担はさらに大きくなります。その結果、潜在的ユーザーは妊孕性温存を選択するのを遅らせたり、避けたりします。これは市場の成長を制限し、高度生殖医療へのアクセスを制限します。

認識と受容の高まり

生殖医療について十分な知識があれば、人々はこうした可能性についてより早く考えるようになります。社会的に受け入れられることでスティグマが軽減され、より多くの人々が不妊治療への理解を深めています。その利点は、メディアの注目やヘルスケア提供者のキャンペーンによってさらに強調されています。また、このような特典を提供する雇用者の間で受け入れが進んでいることも、普及を後押ししています。一般的に、市場の成長と顧客基盤の拡大は、認識と受容によって促進されています。

インフラとアクセス制限

近代的な不妊治療クリニックや専門的な保管施設は多くの地域で不足しています。有資格の医療従事者が不足しているため、サービスの質と範囲が低下しています。凍結保存設備やラボの立ち上げコストが高いため、拡大には限界があります。患者は孤立した場所にあるヘルスケア施設に行くのが困難です。このような障害が市場への浸透を制限し、普及を妨げています。

COVID-19の影響

COVID-19パンデミックは卵子凍結と胚バンク市場を大きく混乱させ、クリニックの閉鎖や渡航制限による不妊治療の遅れを引き起こしました。選択的手術が延期され、サービス需要が一時的に減少しました。サプライチェーンの中断は医療機器や消耗品の入手に影響を与えました。しかし、生殖医療に対する意識の高まりと妊娠の遅れに対する懸念が相まって、パンデミック後は不妊治療への関心が高まりました。遠隔医療とデジタル診察の導入は患者との関係を維持するのに役立ち、クリニックは効率的に業務を再開するために安全プロトコルを強化して適応しました。

予測期間中、ガラス固化セグメントが最大となる見込み

ガラス固化セグメントは、氷結晶の形成を防ぐ急速凍結プロセスを提供し、より高い細胞生存率を確保することで、予測期間中に最大の市場シェアを占めると予想されます。この先進的技術は、卵子と胚の解凍後の生存率を向上させ、受精と妊娠の成功確率を高めています。その効率性と信頼性により、不妊治療クリニックや患者の間で好まれる方法となっています。また、処理時間が短いため、運用コストが削減され、臨床ワークフローが向上します。ガラス固化技術に対する認識の高まりと採用が、世界の市場成長の原動力となっています。

クライオバンク部門は予測期間中最も高いCAGRが見込まれる

予測期間中、生殖材料の長期保存を保証する先進的保管施設により、クライオバンクセグメントが最も高い成長率を示すと予測されます。クライオバンクは安全で温度管理された環境を提供し、卵子や胚の生存性と品質を長期間維持します。クライオバンクはまた、不妊治療クリニックと提携し、便利な回収サービスを提供することでアクセス性を拡大しています。クライオバンクにおける凍結保存方法の技術的進歩は、解凍後の生存率を向上させ、不妊治療の成功率を高めています。

最もシェアの高い地域

予測期間中、北米の地域が最大の市場シェアを占めると予想されるが、これは高い不妊意識、雇用者負担の福利厚生、整備されたヘルスケアインフラが後押ししています。キャリアや教育のために子作りを先延ばしにする傾向が広まっていることと、大企業による卵子凍結保険の提供も普及を大きく加速させています。技術的な利点としては、標準的な凍結保存方法としてのガラス化、タイムラプス画像、AIによる胚選択、主要クリニックに組み込まれた着床前遺伝子検査システムなどが挙げられます。雇用主や保険会社は、これらのサービスに資金を提供し、コストの障壁を軽減し、不妊治療へのアクセスを広げることで重要な役割を果たしています。

CAGRが最も高い地域

予測期間中、アジア太平洋は不妊症の増加、可処分所得の増加、中国、インド、日本、韓国などの国々における都市部での女性労働人口の拡大により、最も高いCAGRを示すと予測されます。東京都の不妊治療助成金やオーストラリアのIVFリベートプログラムの拡大など、国のイニシアチブはアクセシビリティと消費者意識を高めています。技術革新の動向には、超高速ガラス固化、ブロックチェーンによる安全な凍結保存、越境胚バンクの拡大性、地域の遺伝子スクリーニングや胚評価に合わせたAIベース診断ツールなどがあります。また、地域のクリニックが費用対効果の高い先進的不妊治療サービスを提供することで、医療ツーリズムも成長を加速させています。

無料のカスタマイズ提供

本レポートをご購読の顧客には、以下の無料カスタマイズオプションのいずれかをご提供いたします。

企業プロファイル
- 追加市場参入企業の包括的プロファイリング（3社まで）
- 主要企業のSWOT分析（3社まで）
地域セグメンテーション
- 顧客の関心に応じた主要国の市場推定・予測・CAGR（注：フィージビリティチェックによる）
競合ベンチマーキング
- 製品ポートフォリオ、地理的プレゼンス、戦略的提携による主要企業のベンチマーキング

イントロダクション
北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- 英国
- イタリア
- フランス
- スペイン
- その他の欧州
アジア太平洋
- 日本
- 中国
- インド
- オーストラリア
- ニュージーランド
- 韓国
- その他のアジア太平洋
南米
- アルゼンチン
- ブラジル
- チリ
- その他の南米
中東・アフリカ
- サウジアラビア
- アラブ首長国連邦
- カタール
- 南アフリカ
- その他の中東・アフリカ

第12章主要開発

契約、パートナーシップ、コラボレーション、ジョイントベンチャー
買収と合併
新製品発売
事業拡大
その他の主要戦略

第13章企業プロファイリング

The Cooper Companies
Merck KGaA
Thermo Fisher Scientific Inc.
Vitrolife AB
Ferring Pharmaceuticals
Kindbody
Virtus Health Limited
Monash IVF Group
Progyny, Inc.
Shady Grove Fertility
Cryos International
California Cryobank
IVIRMA Global
FUJIFILM Irvine Scientific
Hamilton Thorne Ltd.

図表

List of Tables

Table 1 Global Egg Freezing and Embryo Banking Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
Table 3 Global Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
Table 4 Global Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
Table 5 Global Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
Table 6 Global Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
Table 7 Global Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
Table 8 Global Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
Table 9 Global Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
Table 10 Global Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
Table 11 Global Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
Table 12 Global Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
Table 13 Global Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
Table 14 Global Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
Table 15 Global Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 16 Global Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 17 Global Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 18 Global Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
Table 19 Global Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
Table 20 Global Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
Table 21 Global Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
Table 22 Global Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
Table 23 Global Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
Table 24 Global Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
Table 25 Global Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 26 North America Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
Table 27 North America Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
Table 28 North America Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
Table 29 North America Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
Table 30 North America Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
Table 31 North America Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
Table 32 North America Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
Table 33 North America Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
Table 34 North America Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
Table 35 North America Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
Table 36 North America Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
Table 37 North America Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
Table 38 North America Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
Table 39 North America Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
Table 40 North America Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 41 North America Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 42 North America Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 43 North America Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
Table 44 North America Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
Table 45 North America Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
Table 46 North America Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
Table 47 North America Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
Table 48 North America Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
Table 49 North America Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
Table 50 North America Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 51 Europe Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
Table 52 Europe Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
Table 53 Europe Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
Table 54 Europe Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
Table 55 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
Table 56 Europe Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
Table 57 Europe Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
Table 58 Europe Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
Table 59 Europe Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
Table 60 Europe Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
Table 61 Europe Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
Table 62 Europe Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
Table 63 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
Table 64 Europe Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
Table 65 Europe Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 66 Europe Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 67 Europe Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 68 Europe Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
Table 69 Europe Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
Table 70 Europe Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
Table 71 Europe Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
Table 72 Europe Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
Table 73 Europe Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
Table 74 Europe Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
Table 75 Europe Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 76 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
Table 77 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
Table 78 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
Table 79 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
Table 80 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
Table 81 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
Table 82 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
Table 83 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
Table 84 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
Table 85 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
Table 86 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
Table 87 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
Table 88 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
Table 89 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
Table 90 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 91 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 92 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 93 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
Table 94 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
Table 95 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
Table 96 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
Table 97 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
Table 98 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
Table 99 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
Table 100 Asia Pacific Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 101 South America Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
Table 102 South America Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
Table 103 South America Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
Table 104 South America Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
Table 105 South America Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
Table 106 South America Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
Table 107 South America Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
Table 108 South America Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
Table 109 South America Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
Table 110 South America Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
Table 111 South America Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
Table 112 South America Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
Table 113 South America Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
Table 114 South America Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
Table 115 South America Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 116 South America Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 117 South America Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 118 South America Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
Table 119 South America Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
Table 120 South America Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
Table 121 South America Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
Table 122 South America Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
Table 123 South America Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
Table 124 South America Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
Table 125 South America Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)
Table 126 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Country (2024-2032) ($MN)
Table 127 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Service Type (2024-2032) ($MN)
Table 128 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Egg Freezing (2024-2032) ($MN)
Table 129 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Embryo Banking (2024-2032) ($MN)
Table 130 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Service Types (2024-2032) ($MN)
Table 131 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Preservation Method (2024-2032) ($MN)
Table 132 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Slow Freezing (2024-2032) ($MN)
Table 133 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Vitrification (2024-2032) ($MN)
Table 134 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Age Group (2024-2032) ($MN)
Table 135 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By <30 Years (2024-2032) ($MN)
Table 136 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By 30-39 Years (2024-2032) ($MN)
Table 137 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By >=40 Years (2024-2032) ($MN)
Table 138 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Age Groups (2024-2032) ($MN)
Table 139 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Technology (2024-2032) ($MN)
Table 140 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By In Vitro Fertilization (IVF) (2024-2032) ($MN)
Table 141 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Intracytoplasmic Sperm Injection (ICSI) (2024-2032) ($MN)
Table 142 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other Technologies (2024-2032) ($MN)
Table 143 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Application (2024-2032) ($MN)
Table 144 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Medical Fertility Preservation (2024-2032) ($MN)
Table 145 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Elective Fertility Preservation (2024-2032) ($MN)
Table 146 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By End User (2024-2032) ($MN)
Table 147 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Fertility Clinics (2024-2032) ($MN)
Table 148 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Hospitals (2024-2032) ($MN)
Table 149 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Cryobanks (2024-2032) ($MN)
Table 150 Middle East & Africa Egg Freezing and Embryo Banking Market Outlook, By Other End Users (2024-2032) ($MN)

Product Code: SMRC30399

According to Stratistics MRC, the Global Egg Freezing and Embryo Banking Market is accounted for $5.37 billion in 2025 and is expected to reach $11.7 billion by 2032 growing at a CAGR of 11.8% during the forecast period. A woman's mature eggs are removed, frozen, and saved for later use in a fertility preservation procedure called egg freezing, also known as oocyte cryopreservation, which increases the likelihood of getting pregnant later in life. In order to preserve cell integrity, the procedure entails ovarian stimulation, egg removal, and quick freezing via vitrification. The process of creating, freezing, and storing embryos created by fertilizing eggs with sperm in a lab environment typically through in vitro fertilization (IVF) is known as embryo banking. These techniques, which give people or couples more reproductive flexibility and help, maintain fertility before ageing or medical treatments, are utilized for medical, social, or private reasons.

According to European Society of Human Reproduction and Embryology, more than 3 million ART cycles are performed annually across the world. Therefore, as the adoption of ART procedures expands so does the need for short term shortage.

Market Dynamics:

Driver:

Rising fertility concerns & medical reasons

The need for fertility preservation services has increased as a result of rising infertility rates brought on by stress, delayed family planning, and changes in lifestyle. As a preventative measure to preserve reproductive potential prior to age-related decline, many people choose to freeze their eggs. Before undertaking therapies that may affect fertility, patients with medical problems including cancer, endometriosis, or genetic diseases are also encouraged to preserve their eggs or embryos. Reproductive technology advancements have improved the accessibility and efficacy of these operations. When combined, these elements greatly accelerate the market's expansion and pace of adoption.

Restraint:

High costs & affordability issues

The procedures involve expensive medical treatments, medications, and storage fees. Many individuals, especially in low- and middle-income regions, cannot afford these services. Limited insurance coverage further increases the financial burden. As a result, potential users delay or avoid opting for fertility preservation. This restricts market growth and limits access to advanced reproductive options.

Opportunity:

Growing awareness & acceptance

People are more inclined to think about these possibilities sooner when they are well informed about reproductive health. As stigma is lessened by social acceptability, more people are becoming receptive to fertility preservation. The advantages are further emphasized by media attention and healthcare provider campaigns. Adoption is also aided by growing acceptance among employers who provide these perks. In general, market growth and client base expansion are being facilitated by awareness and acceptance.

Threat:

Infrastructure & access limitations

Modern fertility clinics and specialised storage facilities are scarce in many areas. The quality and scope of services are diminished by the scarcity of qualified medical personnel. Expansion is limited by the high startup costs for cryopreservation equipment and labs. Patients have trouble getting to healthcare facilities in isolated places. These obstacles restrict market penetration and impede adoption.

Covid-19 Impact:

The Covid 19 pandemic significantly disrupted the Egg Freezing and Embryo Banking Market, causing delays in fertility treatments due to clinic closures and travel restrictions. Elective procedures were postponed, leading to a temporary decline in service demand. Supply chain interruptions affected the availability of medical equipment and consumables. However, increased awareness of reproductive health, coupled with concerns over delayed pregnancies, boosted interest in fertility preservation post pandemic. Telemedicine adoption and digital consultations helped sustain patient engagement, while clinics adapted with enhanced safety protocols to resume operations efficiently.

The vitrification segment is expected to be the largest during the forecast period

The vitrification segment is expected to account for the largest market share during the forecast period by offering a rapid-freezing process that prevents ice crystal formation, ensuring higher cell survival rates. This advanced technique improves post-thaw viability of eggs and embryos, increasing the chances of successful fertilization and pregnancy. Its efficiency and reliability make it a preferred method among fertility clinics and patients. The shorter processing time also reduces operational costs and enhances clinical workflow. Growing awareness and adoption of vitrification technology are driving market growth globally.

The cryobanks segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the cryobanks segment is predicted to witness the highest growth rate due to advanced storage facilities that ensure the long-term preservation of reproductive materials. They offer secure and temperature-controlled environments, maintaining the viability and quality of eggs and embryos for extended periods. Cryobanks also expand accessibility by partnering with fertility clinics and offering convenient retrieval services. Technological advancements in cryopreservation methods within cryobanks improve survival rates after thawing, enhancing success rates of fertility treatments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share is propelled by high fertility awareness, supportive employer sponsored benefits, and well developed healthcare infrastructure. The widespread trend of postponing parenthood for careers or education, combined with offers of egg freezing insurance by large corporations, also significantly accelerates adoption. Technological advantages include vitrification as the standard cryopreservation method, time-lapse imaging, AI driven embryo selection, and preimplantation genetic testing systems embedded in leading clinics. Employers and insurers play a key role by funding these services, reducing cost barriers, and widening access to fertility preservation.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR by rising infertility, increasing disposable incomes, and expanding urban female workforce participation in countries such as China, India, Japan, and South Korea. National government initiatives such as fertility subsidies in Tokyo and expanded IVF rebate programs in Australia-boost accessibility and consumer awareness. Innovation trends include ultra rapid vitrification, blockchain secured cry storage, scalability of embryo banks across borders, and AI based diagnostic tools tailored for local genetic screening and embryo assessment. Medical tourism also accelerates growth as regional clinics provide cost-effective, advanced fertility preservation services.

Key players in the market

Some of the key players in Egg Freezing and Embryo Banking Market include The Cooper Companies, Merck KGaA, Thermo Fisher Scientific Inc., Vitrolife AB, Ferring Pharmaceuticals, Kindbody, Virtus Health Limited, Monash IVF Group, Progyny, Inc., Shady Grove Fertility, Cryos International, California Cryobank, IVIRMA Global, FUJIFILM Irvine Scientific and Hamilton Thorne Ltd.

Key Developments:

In February 2025, Thermo Fisher Scientific launched the CorEvitas Systemic Lupus Erythematosus (SLE) Registry, a comprehensive real world clinical data platform. It aims to collect, analyze, and share longitudinal patient data to advance understanding, treatment development, and management strategies for autoimmune diseases.

In May 2024, Vitrolife AB acquired eFertility to integrate its eWitness tracking and eBase EMR systems, enabling secure, efficient, and standardized egg freezing and embryo banking workflows. This move strengthens Vitrolife's end to end IVF platform and advances its digital clinic management capabilities.

In May 2023, Thermo Fisher Scientific partnered with Pfizer to broaden access to lung and breast cancer testing, aiming to enhance early detection and personalized treatment. The collaboration focused on advanced diagnostic solutions, with no link to fertility preservation services.

Service Types Covered:

Egg Freezing
Embryo Banking
Other Service Types

Preservation Methods Covered:

Slow Freezing
Vitrification

Age Groups Covered:

<30 Years
30-39 Years
>=40 Years
Other Age Groups

Technologies Covered:

In Vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)
Other Technologies

Applications Covered:

Medical Fertility Preservation
Elective Fertility Preservation

End Users Covered:

Fertility Clinics
Hospitals
Cryobanks
Other End Users

Regions Covered:

North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
South America
- Argentina
- Brazil
- Chile
- Rest of South America
Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

2 Preface

2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions

3 Market Trend Analysis

3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19

4 Porters Five Force Analysis

4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Egg Freezing and Embryo Banking Market, By Service Type

5.1 Introduction
5.2 Egg Freezing
5.3 Embryo Banking
5.4 Other Service Types

6 Global Egg Freezing and Embryo Banking Market, By Preservation Method

6.1 Introduction
6.2 Slow Freezing
6.3 Vitrification

7 Global Egg Freezing and Embryo Banking Market, By Age Group

7.1 Introduction
7.2 <30 Years
7.3 30-39 Years
7.4 >=40 Years
7.5 Other Age Groups

8 Global Egg Freezing and Embryo Banking Market, By Technology

8.1 Introduction
8.2 In Vitro Fertilization (IVF)
8.3 Intracytoplasmic Sperm Injection (ICSI)
8.4 Other Technologies

9 Global Egg Freezing and Embryo Banking Market, By Application

9.1 Introduction
9.2 Medical Fertility Preservation
9.3 Elective Fertility Preservation

10 Global Egg Freezing and Embryo Banking Market, By End User

10.1 Introduction
10.2 Fertility Clinics
10.3 Hospitals
10.4 Cryobanks
10.5 Other End Users

11 Global Egg Freezing and Embryo Banking Market, By Geography

11.1 Introduction
11.2 North America
- 11.2.1 US
- 11.2.2 Canada
- 11.2.3 Mexico
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 Italy
- 11.3.4 France
- 11.3.5 Spain
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 New Zealand
- 11.4.6 South Korea
- 11.4.7 Rest of Asia Pacific
11.5 South America
- 11.5.1 Argentina
- 11.5.2 Brazil
- 11.5.3 Chile
- 11.5.4 Rest of South America
11.6 Middle East & Africa
- 11.6.1 Saudi Arabia
- 11.6.2 UAE
- 11.6.3 Qatar
- 11.6.4 South Africa
- 11.6.5 Rest of Middle East & Africa

12 Key Developments

12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies

13 Company Profiling

13.1 The Cooper Companies
13.2 Merck KGaA
13.3 Thermo Fisher Scientific Inc.
13.4 Vitrolife AB
13.5 Ferring Pharmaceuticals
13.6 Kindbody
13.7 Virtus Health Limited
13.8 Monash IVF Group
13.9 Progyny, Inc.
13.10 Shady Grove Fertility
13.11 Cryos International
13.12 California Cryobank
13.13 IVIRMA Global
13.14 FUJIFILM Irvine Scientific
13.15 Hamilton Thorne Ltd.

卵子凍結と胚バンク市場の2032年までの予測： サービスタイプ別、保存方法別、年齢層別、技術別、用途別、エンドユーザー別、地域別の世界分析

Egg Freezing and Embryo Banking Market Forecasts to 2032 - Global Analysis By Service Type, Preservation Method, Age Group, Technology, Application, End User and By Geography

COVID-19の影響

最もシェアの高い地域

CAGRが最も高い地域

無料のカスタマイズ提供

本レポートをご購読の顧客には、以下の無料カスタマイズオプションのいずれかをご提供いたします。

目次

第1章 エグゼクティブサマリー

第2章 序文

第3章 市場動向分析

第4章 ポーターのファイブフォース分析

第5章 世界の卵子凍結と胚バンク市場：サービスタイプ別

第6章 世界の卵子凍結と胚バンク市場：保存方法別

第7章 世界の卵子凍結と胚バンク市場：年齢層別

第8章 世界の卵子凍結と胚バンク市場：技術別

第9章 世界の卵子凍結と胚バンク市場：用途別

第10章 世界の卵子凍結と胚バンク市場：エンドユーザー別

第11章 世界の卵子凍結と胚バンク市場：地域別

第12章 主要開発

第13章 企業プロファイリング